CD14 and COVID-19: The detection of the classical CD14+HLA-DR+ monocytes showed a significantly higher percentage in COVID-19 patients (54.7%) compared to HS (26.7%) (Figure 2C, p<0.001) but not the VS (51%) (Figure 2C, p>0.05).